Cargando…
Pre-Vaccination Human Papillomavirus Genotypes and HPV16 Variants among Women Aged 25 Years or Less with Cervical Cancer
Background: In 2007, Australia introduced a national human papillomavirus (HPV) vaccination program. In 2017, the onset of cervical screening changed from 18 to 25 years of age, utilising human papillomavirus (HPV) nucleic acid testing. The objective of the study is to describe the HPV genotypes and...
Autores principales: | Jayasinghe, Yasmin L., Tabrizi, Sepehr N., Stevens, Matthew, Leong, Trishe Y-M., Pyman, Jan, Grover, Sonia R., Garland, Suzanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051959/ https://www.ncbi.nlm.nih.gov/pubmed/36986373 http://dx.doi.org/10.3390/pathogens12030451 |
Ejemplares similares
-
HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples
por: Cornall, Alyssa M., et al.
Publicado: (2017) -
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination program
por: Garland, Suzanne M, et al.
Publicado: (2011) -
Measuring effectiveness of the cervical cancer vaccine in an Australian setting (the VACCINE study)
por: Young, Elisa J, et al.
Publicado: (2013) -
Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
por: BIAN, MEI-LU, et al.
Publicado: (2013) -
Primary Screening for Cervical Cancer Based on High-Risk Human Papillomavirus (HPV) Detection and HPV 16 and HPV 18 Genotyping, in Comparison to Cytology
por: Agorastos, Theodoros, et al.
Publicado: (2015)